0001493152-23-023343.txt : 20230703 0001493152-23-023343.hdr.sgml : 20230703 20230703174602 ACCESSION NUMBER: 0001493152-23-023343 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230701 FILED AS OF DATE: 20230703 DATE AS OF CHANGE: 20230703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ANDREWS DEBORAH J CENTRAL INDEX KEY: 0001325697 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-12830 FILM NUMBER: 231066099 MAIL ADDRESS: STREET 1: 1911 WALKER AVE. CITY: MONROVIA STATE: CA ZIP: 91016 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Lineage Cell Therapeutics, Inc. CENTRAL INDEX KEY: 0000876343 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 943127919 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2173 SALK AVENUE STREET 2: SUITE 200 CITY: CARLSBAD STATE: CA ZIP: 92008 BUSINESS PHONE: 5105213390 MAIL ADDRESS: STREET 1: 2173 SALK AVENUE STREET 2: SUITE 200 CITY: CARLSBAD STATE: CA ZIP: 92008 FORMER COMPANY: FORMER CONFORMED NAME: BIOTIME INC DATE OF NAME CHANGE: 19930328 4 1 ownership.xml X0407 4 2023-07-01 0 0000876343 Lineage Cell Therapeutics, Inc. LCTX 0001325697 ANDREWS DEBORAH J C/O LINEAGE CELL THERAPEUTICS 2173 SALK AVENUE, SUITE 200 CARLSBAD CA 92008 1 0 0 0 0 Stock Option (Right to Buy) 1.41 2023-07-01 4 A 0 50000 0.00 A 2033-07-01 Common Shares 50000 50000 D Will vest and become exercisable on July 1, 2024, subject to the reporting person's continuous service with the issuer. /s/ Alexandra Hernandez, as Attorney-in Fact 2023-07-03